Call Options

6 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 04, 2022

SELL
$9.95 - $12.27 $8,955 - $11,043
-900 Reduced 4.07%
21,200 $3,000
Q1 2022

Apr 14, 2022

SELL
$9.81 - $15.4 $486,576 - $763,840
-49,600 Reduced 69.18%
22,100 $3,000
Q4 2021

Jan 18, 2022

SELL
$12.09 - $14.68 $170,469 - $206,988
-14,100 Reduced 16.43%
71,700 $20,000
Q3 2021

Oct 26, 2021

BUY
$13.25 - $15.13 $1 Million - $1.15 Million
75,800 Added 758.0%
85,800 $51,000
Q1 2021

Apr 26, 2021

SELL
$13.59 - $18.54 $55,719 - $76,014
-4,100 Reduced 29.08%
10,000 $0
Q4 2020

Jan 21, 2021

BUY
$14.3 - $18.74 $201,630 - $264,234
14,100 New
14,100 $1,000

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $15.8B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.